ELDN Stock Price
Eledon Pharmaceuticals, Inc.
ELDN stock price is $2.25 (-3.85% on the day), giving Eledon Pharmaceuticals, Inc. a market cap of $182.84M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ELDN Stock Overview
- Price
- $2.25
- Previous close
- $2.34
- Open
- $2.31
- Market cap
- $182.84M
- P/E ratio
- -4.0
- 52-week range
- $1.29 - $4.49
- 1-year price target
- $9.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 28
About Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for kidney transplantation, xenotransplantation, and liver transplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELDN | $2.25 | -3.8% | 987.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Eledon Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW